CS119492A3 - N-hydroxy-n-/3-/2-/halophenylthio/phenyl/prop-2-enyl/urea and apharmaceutical composition comprising thereof - Google Patents

N-hydroxy-n-/3-/2-/halophenylthio/phenyl/prop-2-enyl/urea and apharmaceutical composition comprising thereof Download PDF

Info

Publication number
CS119492A3
CS119492A3 CS921194A CS119492A CS119492A3 CS 119492 A3 CS119492 A3 CS 119492A3 CS 921194 A CS921194 A CS 921194A CS 119492 A CS119492 A CS 119492A CS 119492 A3 CS119492 A3 CS 119492A3
Authority
CS
Czechoslovakia
Prior art keywords
prop
hydroxy
enyl
phenyl
urea
Prior art date
Application number
CS921194A
Other languages
Czech (cs)
English (en)
Inventor
Gary Alan Hite
Edward David Mihelich
David Wells Snyder
Tulio Suarez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS119492A3 publication Critical patent/CS119492A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/47—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS921194A 1991-04-23 1992-04-17 N-hydroxy-n-/3-/2-/halophenylthio/phenyl/prop-2-enyl/urea and apharmaceutical composition comprising thereof CS119492A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69020491A 1991-04-23 1991-04-23

Publications (1)

Publication Number Publication Date
CS119492A3 true CS119492A3 (en) 1992-12-16

Family

ID=24771539

Family Applications (1)

Application Number Title Priority Date Filing Date
CS921194A CS119492A3 (en) 1991-04-23 1992-04-17 N-hydroxy-n-/3-/2-/halophenylthio/phenyl/prop-2-enyl/urea and apharmaceutical composition comprising thereof

Country Status (17)

Country Link
US (1) US5283361A (fi)
EP (1) EP0510948A1 (fi)
JP (1) JPH05117227A (fi)
KR (1) KR920019740A (fi)
CN (1) CN1066062A (fi)
AU (1) AU638641B2 (fi)
BR (1) BR9201452A (fi)
CA (1) CA2066508A1 (fi)
CS (1) CS119492A3 (fi)
FI (1) FI921786A (fi)
HU (1) HUT62557A (fi)
IE (1) IE921279A1 (fi)
IL (1) IL101625A0 (fi)
MX (1) MX9201808A (fi)
NO (1) NO921530L (fi)
TW (1) TW199141B (fi)
ZA (1) ZA922873B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物
JP2756732B2 (ja) * 1993-12-22 1998-05-25 ファイザー製薬株式会社 リポキシゲナーゼ阻害剤としてのフェニルチオフェニルシクロアルケニルヒドロキシ尿素
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
JP3929140B2 (ja) * 1997-10-27 2007-06-13 日本碍子株式会社 耐蝕性部材およびその製造方法
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
CN102659637B (zh) * 2012-05-21 2014-05-14 上海大学 一种制备双羟基脲的新方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE80611T1 (de) * 1985-03-16 1992-10-15 Wellcome Found Aryl-derivate.
US5185363A (en) * 1986-04-25 1993-02-09 Abbott Laboratories Urea based lipoxygenase inhibiting compounds
GB8619593D0 (en) * 1986-08-12 1986-09-24 Roussel Lab Ltd Chemical compounds
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
DE69004119T2 (de) * 1989-02-03 1994-03-24 Wellcome Found Entzündungshemmende Arylderivate.
JPH04504261A (ja) * 1989-03-30 1992-07-30 アボツト・ラボラトリーズ 尿素系リポキシゲナーゼ阻害化合物
US5130485A (en) * 1991-04-23 1992-07-14 Eli Lilly And Company N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents

Also Published As

Publication number Publication date
AU638641B2 (en) 1993-07-01
BR9201452A (pt) 1992-12-01
IL101625A0 (en) 1992-12-30
US5283361A (en) 1994-02-01
TW199141B (fi) 1993-02-01
CA2066508A1 (en) 1992-10-24
NO921530L (no) 1992-10-26
FI921786A (fi) 1992-10-24
IE921279A1 (en) 1992-11-04
MX9201808A (es) 1994-05-31
ZA922873B (en) 1993-10-21
FI921786A0 (fi) 1992-04-22
EP0510948A1 (en) 1992-10-28
AU1500992A (en) 1992-10-29
CN1066062A (zh) 1992-11-11
KR920019740A (ko) 1992-11-19
HUT62557A (en) 1993-05-28
HU9201343D0 (en) 1992-07-28
JPH05117227A (ja) 1993-05-14
NO921530D0 (no) 1992-04-21

Similar Documents

Publication Publication Date Title
US5955495A (en) Method of treating diseases of the CNS
EP1414788A1 (en) Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
JPH08508741A (ja) 虚血および関連疾患の処置におけるヘテロ環誘導体類
JPH0637443B2 (ja) １−フェニル−３−ナフタレニルオキシプロパンアミン類
US6107328A (en) Use of 5HT1B receptor antagonist for the treatment of vascular disease
CZ397598A3 (cs) Derivát 5-fenoxyalkyl-2,4-thiazolidindionu, způsob jeho přípravy, meziprodukty pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
JPS6051138A (ja) ロイコトリエン拮抗物質
EP0091795A1 (en) Olefinic benzimidazoles
CA1161053A (en) Secondary amines, their preparation and use in pharmaceutical compositions
US4413006A (en) N-Aryl-N-phenoxy-alkyl-piperazine compounds useful in decreasing intracranial pressure
IE58352B1 (en) Benzocycloalkane derivatives
US4749701A (en) Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing SRS by employing the same
CS119492A3 (en) N-hydroxy-n-/3-/2-/halophenylthio/phenyl/prop-2-enyl/urea and apharmaceutical composition comprising thereof
CZ159893A3 (en) Derivatives of 1,4-benzodioxan, process of their preparation and pharmaceutical preparations in which they are comprised
US4255575A (en) 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives
US4876282A (en) 1-Phenylalkylamines as selective serotonin uptake inhibitors
AU647911B2 (en) N-hydroxy-N-{3-(2-substituted phenyl)prop-2-enyl} ureas and thioureas, compositions thereof and methods of use
US4562199A (en) Imidazole derivatives, compositions and use
US5354769A (en) Benzofuranylimidazole derivatives and therapeutical compositions containing the same
EP0106060B1 (en) Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations
EP0034752B1 (en) Phenoxyalkane derivative and processes for preparing same
SU1600627A3 (ru) Способ получени 2-замещенных 1-нафтолов
CZ453699A3 (cs) Způsob a meziprodukty pro přípravu inhibitorů 5-lipoxygenasy
GB2126218A (en) Imidazoles
JPS63290852A (ja) 化合物